Dermata Therapeutics Inc
NASDAQ:DRMA
Balance Sheet
Balance Sheet Decomposition
Dermata Therapeutics Inc
Dermata Therapeutics Inc
Balance Sheet
Dermata Therapeutics Inc
| Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|
| Assets | |||||||
| Cash & Cash Equivalents |
2
|
1
|
11
|
6
|
7
|
3
|
|
| Cash |
2
|
1
|
11
|
6
|
7
|
3
|
|
| Total Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
0
|
0
|
1
|
1
|
1
|
0
|
|
| Total Current Assets |
2
|
1
|
12
|
7
|
8
|
4
|
|
| PP&E Net |
0
|
0
|
0
|
0
|
0
|
0
|
|
| PP&E Gross |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
2
N/A
|
1
-71%
|
12
+1 821%
|
7
-40%
|
8
+15%
|
4
-56%
|
|
| Liabilities | |||||||
| Accounts Payable |
0
|
0
|
1
|
0
|
1
|
1
|
|
| Accrued Liabilities |
0
|
0
|
1
|
0
|
1
|
1
|
|
| Short-Term Debt |
0
|
3
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
1
|
1
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
1
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Liabilities |
2
|
4
|
2
|
1
|
2
|
2
|
|
| Long-Term Debt |
1
|
0
|
0
|
0
|
0
|
0
|
|
| Total Liabilities |
2
N/A
|
4
+66%
|
2
-60%
|
1
-39%
|
2
+76%
|
2
+21%
|
|
| Equity | |||||||
| Common Stock |
25
|
25
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
25
|
28
|
36
|
46
|
53
|
66
|
|
| Additional Paid In Capital |
0
|
0
|
46
|
52
|
60
|
67
|
|
| Total Equity |
0
N/A
|
3
-1 413%
|
10
N/A
|
6
-40%
|
6
+6%
|
2
-75%
|
|
| Total Liabilities & Equity |
2
N/A
|
1
-71%
|
12
+1 821%
|
7
-40%
|
8
+15%
|
4
-56%
|
|
| Shares Outstanding | |||||||
| Common Shares Outstanding |
0
|
0
|
0
|
0
|
0
|
0
|
|